In addition, increasing the plasma glucagon concentration [26] and hepatic gluconeogenesis [26], and enhancing lipolysis in patients with type 2 diabetes mellitus may also prevent hypoglycemia [27]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.